News
Cantor Fitzgerald Reiterates Overweight on X4 Pharmaceuticals, Maintains $5 Price Target
31 May 24
News, Price Target, Reiteration, Analyst Ratings
X4 Pharmaceuticals Q1 2024 GAAP EPS $(0.26) Misses $(0.16) Estimate
7 May 24
Earnings, Earnings Misses, News
HC Wainwright & Co. Maintains Buy on X4 Pharmaceuticals, Raises Price Target to $5
30 Apr 24
News, Price Target, Analyst Ratings
FDA Approves X4 Pharmaceuticals' Mavorixafor As First Therapy For Rare Immunodeficiency Disorder
29 Apr 24
Biotech, News, Health Care, FDA, General
12 Health Care Stocks Moving In Friday's Intraday Session
26 Apr 24
Movers
HC Wainwright & Co. Reiterates Buy on X4 Pharmaceuticals, Maintains $3 Price Target
22 Mar 24
News, Price Target, Reiteration, Analyst Ratings
12 Health Care Stocks Moving In Thursday's Intraday Session
21 Mar 24
Movers
Earnings Scheduled For March 21, 2024
21 Mar 24
Earnings
Recap: X4 Pharmaceuticals Q4 Earnings
21 Mar 24
Earnings
X4 Pharmaceuticals Q4 EPS $(0.10) Beats $(0.15) Estimate
21 Mar 24
Earnings, News
X4 Pharmaceuticals's Earnings Outlook
20 Mar 24
Earnings
Press releases
X4 Pharmaceuticals to Host Virtual Investor Event on June 27, 2024 to Review New Mavorixafor Clinical Data from Ongoing Phase 2 Trial in Chronic Neutropenia
29 May 24
News, Press Releases, General
X4 Pharmaceuticals to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference
13 May 24
News, Press Releases
X4 Pharmaceuticals Announces $125 Million Capital Infusion from $105 Million Sale of Priority Review Voucher and $20 Million Drawdown from Existing Loan Facility
9 May 24
News, Health Care, Financing, Press Releases
X4 Pharmaceuticals Reports First-Quarter 2024 Financial Results and Provides Corporate Updates
7 May 24
Earnings, Press Releases
X4 Pharmaceuticals Announces FDA Approval of XOLREMDI™ (mavorixafor) Capsules, First Drug Indicated in Patients with WHIM Syndrome
29 Apr 24
Press Releases
X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2 Apr 24
Press Releases
X4 Pharmaceuticals Reports Fourth-Quarter and Full-Year 2023 Financial Results and Provides Corporate Update
21 Mar 24
Earnings, Press Releases
Thinking about buying stock in Marpai, Axcelis Technologies, Amylyx Pharmaceuticals, Biomx, or X4 Pharmaceuticals?
11 Mar 24
Small Cap, Opinion, Press Releases